tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sangamo Biosciences: Cautious Optimism in Earnings Call
PremiumCompany AnnouncementsSangamo Biosciences: Cautious Optimism in Earnings Call
2M ago
Sangamo Biosciences: Strategic Positioning and Growth Potential Drive Buy Rating
Premium
Ratings
Sangamo Biosciences: Strategic Positioning and Growth Potential Drive Buy Rating
2M ago
Sangamo Therapeutics Reports Strong Q2 2025 Results
Premium
Company Announcements
Sangamo Therapeutics Reports Strong Q2 2025 Results
2M ago
Sangamo Announces Positive Results for Fabry Disease Therapy
PremiumCompany AnnouncementsSangamo Announces Positive Results for Fabry Disease Therapy
4M ago
Sangamo announces topline results from STAAR study
Premium
The Fly
Sangamo announces topline results from STAAR study
4M ago
Sangamo Biosciences Approves Amendments to Equity Plan
Premium
Company Announcements
Sangamo Biosciences Approves Amendments to Equity Plan
4M ago
Sangamo Biosciences: Promising Genomic Medicine Pipeline and Strategic Advancements Justify Buy Rating
PremiumRatingsSangamo Biosciences: Promising Genomic Medicine Pipeline and Strategic Advancements Justify Buy Rating
5M ago
Sangamo price target lowered to $5 from $9 at Barclays
Premium
The Fly
Sangamo price target lowered to $5 from $9 at Barclays
5M ago
Sangamo Biosciences Announces $23 Million Share Offering
Premium
Company Announcements
Sangamo Biosciences Announces $23 Million Share Offering
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100